{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:54:25Z","timestamp":1786992865052,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jmii.2020.04.017","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T13:03:58Z","timestamp":1589202238000},"page":"627-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["In\u00a0vitro susceptibility of ceftaroline against clinically important Gram-positive cocci, Haemophilus species and Klebsiella pneumoniae in Taiwan: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012\u20132018"],"prefix":"10.1016","volume":"54","author":[{"given":"Shio-Shin","family":"Jean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Sen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2020.04.017_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jmii.2018.11.004","article-title":"Recommendations and guidelines for the treatment of pneumonia in Taiwan","volume":"52","author":"Chou","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2020.04.017_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jmii.2017.07.011","article-title":"Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: a phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial","volume":"52","author":"Yuan","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2020.04.017_bib3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jmii.2019.04.001","article-title":"Role of nasal swab culture in guiding antimicrobial therapy for acute cellulitis in the era of community-acquired methicillin-resistant Staphylococcus aureus: a prospective study of 89 patients","volume":"52","author":"Hsu","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2020.04.017_bib4","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/jac\/dku114","article-title":"Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective","volume":"69","author":"Alm","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2020.04.017_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jmii.2018.08.015","article-title":"Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus among nasal carriage strains isolated from emergency department patients and healthcare workers in central Taiwan","volume":"52","author":"Wu","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2020.04.017_bib6","author":"Jean","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2020.04.017_bib7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jfma.2015.07.011","article-title":"Risk factors for in-hospital mortality in patients with type 2 diabetes complicated by community-acquired Klebsiella pneumoniae bacteremia","volume":"114","author":"Huang","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2020.04.017_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.diagmicrobio.2016.07.012","article-title":"In\u00a0vitro activity of ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in African and Middle Eastern countries: AWARE global surveillance program 2012-2014","volume":"86","author":"Karlowsky","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2020.04.017_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/dkq252","article-title":"Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study","volume":"65","author":"Jones","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2020.04.017_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jgar.2019.02.018","article-title":"Bactericidal activity of ceftaroline, vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolates from cancer patients","volume":"17","author":"Rolston","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jmii.2020.04.017_bib11","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for antimicrobial susceptibility testing: twenty-twentieth informational supplement M100-S30. CLSI, Wayne, PA, CLSI; 2020."},{"key":"10.1016\/j.jmii.2020.04.017_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijantimicag.2014.12.023","article-title":"Pharmacokinetic\/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function","volume":"45","author":"Canut","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2020.04.017_bib13","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1517\/17425255.2014.972932","article-title":"Pharmacokinetic and pharmacodynamic evaluation of ceftaroline fosamil","volume":"10","author":"Merker","year":"2014","journal-title":"Expet Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.jmii.2020.04.017_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijantimicag.2014.12.014","article-title":"A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: susceptibility to ceftaroline and molecular epidemiology","volume":"45","author":"Zhang","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2020.04.017_bib15","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.3390\/jcm9010275","article-title":"Epidemiology, treatment, and prevention of nosocomial bacterial pneumonia","volume":"9","author":"Jean","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jmii.2020.04.017_bib16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jmii.2016.12.004","article-title":"Invasive pneumococcal disease caused by ceftriaxone-resistant Streptococcus pneumoniae in Taiwan","volume":"51","author":"Lee","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2020.04.017_bib17","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1128\/AAC.00019-10","article-title":"Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae","volume":"54","author":"Kosowska-Shick","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.04.017_bib18","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1093\/ofid\/ofy263","article-title":"Antimicrobial susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific region: results from 20 years of the SENTRY antimicrobial surveillance program (1997-2016)","volume":"6","author":"Sader","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2020.04.017_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12931-018-0905-x","article-title":"Efficacy and effectiveness of ceftaroline fosamil in patients with pneumonia: a systematic review and meta-analysis","volume":"19","author":"Sotgiu","year":"2018","journal-title":"Respir Res"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118220301109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118220301109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:27:00Z","timestamp":1761658020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118220301109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1684118220301109"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2020.04.017","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro susceptibility of ceftaroline against clinically important Gram-positive cocci, Haemophilus species and Klebsiella pneumoniae in Taiwan: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012\u20132018","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2020.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}